Upsher-Smith Laboratories
TypeSubsidiary of publicly traded company
IndustryPharmaceuticals
Founded1919 (1919) in Wayzata, Minnesota, U.S.
HeadquartersMaple Grove, Minnesota, U.S.
Key people
Productsgeneric drugs, pharmaceutical drugs
ParentSawai Group Holdings Co., Ltd.
Websitewww.upsher-smith.com

Upsher-Smith Laboratories, LLC is a century-old American pharmaceutical company based in Maple Grove, Minnesota that brings brands and generics to a wide array of customers. Upsher-Smith is owned by Japan-based Sawai Group Holdings Co., Ltd..

Locations

History

Founded in 1919 as a maker of digitalis drugs,[4] Upsher-Smith has traditionally focused on the manufacture of generic medications. In 2017, after owning and operating Upsher-Smith for 47 years, the Evenstad family made the decision to sell the largest part of their company, the generics business, to Sawai Group Holdings Co., Ltd., a large publicly traded generics company in Japan that had been seeking entry into the U.S. market.[5]

Upsher-Smith's non-generic pharmaceuticals businesses, Proximagen, Pairnomix, and MOBĒ, remained with ACOVA, a holding company owned by the Evenstads.

Products

Upsher-Smith offers brand and generic pharmaceuticals to treat the following disease states:[6]

References

  1. ↑ "Taku Nakaoka Named CEO of Upsher-Smith Laboratories".
  2. ↑ "Executive Team".
  3. 1 2 3 "Locations – Upsher-Smith". Upsher-Smith Laboratories, LLC. Retrieved 2022-06-21.
  4. ↑ "Upsher-Smith History".
  5. ↑ "Sawai Pharmaceutical Completes Acquisition of Upsher-Smith Laboratories Generics Business". May 31, 2017.
  6. ↑ "Upsher-Smith Products".
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.